These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 2049177)

  • 1. A sensitive method for measuring neutralizing antibodies to Bordetella pertussis toxin: optimized ADP-ribosylation of transducin.
    Magnusson R; Larsson U; Bartfai T; Askelöf P
    Biologicals; 1991 Jan; 19(1):9-15. PubMed ID: 2049177
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Failure of [32P]ADP-ribosylation by pertussis toxin to determine Gi alpha content in membranes from various human tissues. Improved radioimmunological quantification using the 125I-labelled C-terminal decapeptide of retinal transducin.
    Böhm M; Larisch K; Erdmann E; Camps M; Jakobs K; Gierschik P
    Biochem J; 1991 Jul; 277 ( Pt 1)(Pt 1):223-9. PubMed ID: 1906710
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A quantitative analysis for the ADP-ribosylation activity of pertussis toxin: an enzymatic-HPLC coupled assay applicable to formulated whole cell and acellular pertussis vaccine products.
    Cyr T; Menzies AJ; Calver J; Whitehouse LW
    Biologicals; 2001 Jun; 29(2):81-95. PubMed ID: 11580213
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Protective immunogenicity of synthetic peptides selected from the amino acid sequence of Bordetella pertussis toxin subunit S1.
    Askelöf P; Rodmalm K; Wrangsell G; Larsson U; Svenson SB; Cowell JL; Undén A; Bartfai T
    Dev Biol Stand; 1991; 73():111-20. PubMed ID: 1778305
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Determination of circulating antibodies directed to pertussis toxin and of agglutinogens in children vaccinated with either the whole cell or component pertussis vaccine in France, Japan and Senegal.
    Relyveld E; Oato NH; Guérin N; Coursaget P; Huet M; Gupta RK
    Vaccine; 1991 Nov; 9(11):843-50. PubMed ID: 1759508
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular characterization of the in vitro activation of pertussis toxin by ATP.
    Krueger KM; Barbieri JT
    J Biol Chem; 1993 Jun; 268(17):12570-8. PubMed ID: 8509398
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Monoclonal antibodies to pertussis toxin: utilization as probes of toxin function.
    Kenimer JG; Kim KJ; Probst PG; Manclark CR; Burstyn DG; Cowell JL
    Hybridoma; 1989 Feb; 8(1):37-51. PubMed ID: 2466764
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mucosal and systemic immunogenicity of a recombinant, non-ADP-ribosylating pertussis toxin: effects of formaldehyde treatment.
    Cropley I; Douce G; Roberts M; Chatfield S; Pizza M; Marsili I; Rappuoli R; Dougan G
    Vaccine; 1995 Dec; 13(17):1643-8. PubMed ID: 8719514
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum IgG antibody responses to pertussis toxin and filamentous hemagglutinin in nonvaccinated and vaccinated children and adults with pertussis.
    Trollfors B; Taranger J; Lagergård T; Sundh V; Bryla DA; Schneerson R; Robbins JB
    Clin Infect Dis; 1999 Mar; 28(3):552-9. PubMed ID: 10194077
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The carboxyl terminus of the S1 subunit of pertussis toxin confers high affinity binding to transducin.
    Cortina G; Krueger KM; Barbieri JT
    J Biol Chem; 1991 Dec; 266(35):23810-4. PubMed ID: 1748655
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Determination of antibodies to pertussis toxin in working reference preparations of anti-pertussis sera from various national control laboratories.
    Relyveld E; Oato NH; Huet M; Gupta RK
    Biologicals; 1992 Mar; 20(1):67-71. PubMed ID: 1610560
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunogenicity of an acellular pertussis vaccine composed of genetically inactivated pertussis toxin combined with filamentous hemagglutinin and pertactin in infants and children.
    Podda A; Carapella De Luca E; Titone L; Casadei AM; Cascio A; Bartalini M; Volpini G; Peppoloni S; Marsili I; Nencioni L
    J Pediatr; 1993 Jul; 123(1):81-4. PubMed ID: 8320630
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Acellular pertussis vaccines: neutralization by immune sera of the lethality of pertussis toxin and viable Bordetella pertussis for chick embryos.
    Calver GA
    Biologicals; 1999 Jun; 27(2):143-7. PubMed ID: 10600203
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Description and evaluation of serologic assays used in a multicenter trial of acellular pertussis vaccines.
    Meade BD; Deforest A; Edwards KM; Romani TA; Lynn F; O'Brien CH; Swartz CB; Reed GF; Deloria MA
    Pediatrics; 1995 Sep; 96(3 Pt 2):570-5. PubMed ID: 7659478
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of Anti-PT Antibody Response after Pertussis Vaccination and Infection: The Importance of Both Quantity and Quality.
    Barkoff AM; Knuutila A; Mertsola J; He Q
    Toxins (Basel); 2021 Jul; 13(8):. PubMed ID: 34437379
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Crystal structures of pertussis toxin with NAD
    Sakari M; Tran MT; Rossjohn J; Pulliainen AT; Beddoe T; Littler DR
    J Biol Chem; 2022 May; 298(5):101892. PubMed ID: 35378130
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Functional modifications of transducin induced by cholera or pertussis-toxin-catalyzed ADP-ribosylation.
    Bornancin F; Franco M; Bigay J; Chabre M
    Eur J Biochem; 1992 Nov; 210(1):33-44. PubMed ID: 1332864
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A specific beta gamma-subunit of transducin stimulates ADP-ribosylation of the alpha-subunit by pertussis toxin.
    Ohguro H; Fukada Y; Yoshizawa T; Saito T; Akino T
    Biochem Biophys Res Commun; 1990 Mar; 167(3):1235-41. PubMed ID: 2322268
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Distribution of pertussis antibodies among different age groups in Japan.
    Konda T; Kamachi K; Iwaki M; Matsunaga Y
    Vaccine; 2002 Mar; 20(13-14):1711-7. PubMed ID: 11906757
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of a tetraplex microsphere assay for Bordetella pertussis antibodies.
    Prince HE; Lapé-Nixon M; Matud J
    Clin Vaccine Immunol; 2006 Feb; 13(2):266-70. PubMed ID: 16467336
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.